









Markets
/
Stocks
/
nasdaq-mdt
/

Medtronic PLC

MDT

101.000USD

+0.210+0.21%

Close 01/29, 16:00（ET）Quotes delayed by 15 min

129.48BMarket Cap

27.18P/E TTM



Medtronic PLC

101.000

+0.210+0.21%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Medtronic PLC

Currency: USD Updated: 2026-01-29

Key Insights

Medtronic PLC's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 108.89.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Medtronic PLC's Score

Industry at a Glance

Industry Ranking

15 / 205

Overall Ranking

79 / 4540

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

48°C



Very Low

Very High

Positive

Medtronic PLC Highlights

StrengthsRisks

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 33.54B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 76.98%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 76.98%.

Fairly Valued

The company’s latest PE is 27.18, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 1.13B shares, decreasing 1.50% quarter-over-quarter.

Held by Scotia Canadian Dividend Fund

Star Investor Scotia Canadian Dividend Fund holds 111.67K shares of this stock.

Analyst Rating

Based on 29 analysts

Buy

Current Rating

108.893

Target Price

+8.15%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-29

The current financial score of Medtronic PLC is 7.26, ranking 95 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 8.96B, representing a year-over-year increase of 6.64%, while its net profit experienced a year-over-year increase of 8.19%.

Score

Industry at a Glance

Previous score

7.26

Change



Financials

7.26

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.26

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.26

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.26

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.26

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Medtronic PLC's Company Valuation

Currency: USD Updated: 2026-01-29

The current valuation score of Medtronic PLC is 8.45, ranking 19 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 27.18, which is 19.28% below the recent high of 32.42 and 18.16% above the recent low of 22.25.

Score

Industry at a Glance

Previous score

8.45

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 15/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-29

The current earnings forecast score of Medtronic PLC is 7.38, ranking 133 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 111.00, with a high of 125.00 and a low of 92.00.

Score

Industry at a Glance

Previous score

7.38

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 29 analysts

Buy

Current Rating

108.893

Target Price

+8.15%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

Insulet Corp

PODD

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-29

The current price momentum score of Medtronic PLC is 9.13, ranking 15 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 103.68 and the support level at 96.75, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.05

Change

0.08

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.639

Buy

RSI(14)

58.608

Neutral

STOCH(KDJ)(9,3,3)

80.863

Neutral

ATR(14)

2.024

Low Volatility

CCI(14)

65.110

Neutral

Williams %R

17.147

Overbought

TRIX(12,20)

0.090

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

100.806

Buy

MA10

100.002

Buy

MA20

98.895

Buy

MA50

99.604

Buy

MA100

97.021

Buy

MA200

92.379

Buy

Institutional Confidence

Currency: USD Updated: 2026-01-29

The current institutional shareholding score of Medtronic PLC is 7.00, ranking 82 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 88.21%, representing a quarter-over-quarter increase of 0.01%. The largest institutional shareholder is The Vanguard, holding a total of 130.95M shares, representing 10.21% of shares outstanding, with 5.27% increase in holdings.

Score

Industry at a Glance

Previous score

7.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

130.95M

+3.55%

BlackRock Institutional Trust Company, N.A.

66.42M

-2.10%

State Street Investment Management (US)

60.46M

+1.05%

JP Morgan Asset Management

37.48M

+42.48%

Capital Research Global Investors

30.69M

-15.58%

Geode Capital Management, L.L.C.

27.65M

-2.05%

MFS Investment Management

19.44M

+0.39%

Norges Bank Investment Management (NBIM)

16.44M

+12.83%

Managed Account Advisors LLC

14.98M

+8.79%

BlackRock Financial Management, Inc.

14.32M

-8.33%

Risk Assessment

Currency: USD Updated: 2026-01-29

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Medtronic PLC is 9.76, ranking 2 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.72. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.